SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0000950123-24-007171
Filing Date
2024-08-05
Accepted
2024-08-05 17:22:43
Documents
24
Effectiveness Date
2024-08-05

Document Format Files

Seq Description Document Type Size
1 FORM S-3ASR crsp-20240805.htm S-3ASR 781581
2 EX-4.1 crsp-ex4_1.htm EX-4 707959
3 EX-4.2 crsp-ex4_2.htm EX-4 669963
4 EX-5.1 crsp-ex5_1.htm EX-5 65532
5 EX-5.2 crsp-ex5_2.htm EX-5 88802
6 EX-5.3 crsp-ex5_3.htm EX-5 28168
7 EX-23.1 crsp-ex23_1.htm EX-23 4071
8 EX-FILING FEES EXFILINGFEES.htm   iXBRL EX-FILING FEES 50559
9 GRAPHIC img35317384_0.jpg GRAPHIC 10933
10 GRAPHIC img169350318_0.jpg GRAPHIC 1009492
11 GRAPHIC img169350318_1.jpg GRAPHIC 1009492
12 GRAPHIC img169350318_2.jpg GRAPHIC 1009492
  Complete submission text file 0000950123-24-007171.txt   6777851

Data Files

Seq Description Document Type Size
26 EXTRACTED XBRL INSTANCE DOCUMENT EXFILINGFEES_htm.xml XML 19167
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-281262 | Film No.: 241176126
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)